rs201131315
Positions:
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PP2PP3BP6BS2
The NM_001035.3(RYR2):āc.2711A>Gā(p.Tyr904Cys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000956 in 1,610,920 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: š 0.00016 ( 0 hom., cov: 33)
Exomes š: 0.000088 ( 0 hom. )
Consequence
RYR2
NM_001035.3 missense
NM_001035.3 missense
Scores
13
4
1
Clinical Significance
Conservation
PhyloP100: 7.36
Genes affected
RYR2 (HGNC:10484): (ryanodine receptor 2) This gene encodes a ryanodine receptor found in cardiac muscle sarcoplasmic reticulum. The encoded protein is one of the components of a calcium channel, composed of a tetramer of the ryanodine receptor proteins and a tetramer of FK506 binding protein 1B proteins, that supplies calcium to cardiac muscle. Mutations in this gene are associated with stress-induced polymorphic ventricular tachycardia and arrhythmogenic right ventricular dysplasia. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -3 ACMG points.
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), RYR2. . Gene score misZ 5.7809 (greater than the threshold 3.09). Trascript score misZ 6.4158 (greater than threshold 3.09). GenCC has associacion of gene with hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy, catecholaminergic polymorphic ventricular tachycardia 1, arrhythmogenic right ventricular dysplasia 2, catecholaminergic polymorphic ventricular tachycardia.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.807
BP6
Variant 1-237506807-A-G is Benign according to our data. Variant chr1-237506807-A-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 179436.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=4, Uncertain_significance=4}.
BS2
High AC in GnomAd4 at 25 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RYR2 | NM_001035.3 | c.2711A>G | p.Tyr904Cys | missense_variant | 23/105 | ENST00000366574.7 | NP_001026.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RYR2 | ENST00000366574.7 | c.2711A>G | p.Tyr904Cys | missense_variant | 23/105 | 1 | NM_001035.3 | ENSP00000355533 | P1 | |
RYR2 | ENST00000660292.2 | c.2711A>G | p.Tyr904Cys | missense_variant | 23/106 | ENSP00000499787 | ||||
RYR2 | ENST00000659194.3 | c.2711A>G | p.Tyr904Cys | missense_variant | 23/105 | ENSP00000499653 | ||||
RYR2 | ENST00000609119.2 | c.2711A>G | p.Tyr904Cys | missense_variant, NMD_transcript_variant | 23/104 | 5 | ENSP00000499659 |
Frequencies
GnomAD3 genomes AF: 0.000164 AC: 25AN: 152214Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
25
AN:
152214
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000145 AC: 36AN: 248642Hom.: 0 AF XY: 0.000126 AC XY: 17AN XY: 134906
GnomAD3 exomes
AF:
AC:
36
AN:
248642
Hom.:
AF XY:
AC XY:
17
AN XY:
134906
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000884 AC: 129AN: 1458706Hom.: 0 Cov.: 29 AF XY: 0.0000758 AC XY: 55AN XY: 725872
GnomAD4 exome
AF:
AC:
129
AN:
1458706
Hom.:
Cov.:
29
AF XY:
AC XY:
55
AN XY:
725872
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000164 AC: 25AN: 152214Hom.: 0 Cov.: 33 AF XY: 0.000148 AC XY: 11AN XY: 74360
GnomAD4 genome
AF:
AC:
25
AN:
152214
Hom.:
Cov.:
33
AF XY:
AC XY:
11
AN XY:
74360
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
0
ALSPAC
AF:
AC:
1
ExAC
AF:
AC:
14
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:4Benign:5
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Uncertain:3Benign:1
Uncertain significance, criteria provided, single submitter | research | Biesecker Lab/Clinical Genomics Section, National Institutes of Health | Jun 24, 2013 | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Mar 01, 2024 | RYR2: BS2 - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Aug 18, 2023 | Identified in an individual with a sudden cardiac arrest who later received a heart transplant and an individual with facioscapulohumeral muscular dystrophy and hypertrophic cardiomyopathy in the published literature; however, both individuals harbored additional cardiogenetic variants that may explain their phenotypes (Cuenca et al., 2016; Lima et al., 2017); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Not located in one of the three hot-spot regions of the RYR2 gene, where the majority of pathogenic missense variants occur (Medeiros-Domingo et al., 2009); This variant is associated with the following publications: (PMID: 23861362, 26899768, 28697927, 19926015, 28404607) - |
Uncertain significance, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Aug 24, 2023 | The RYR2 c.2711A>G; p.Tyr904Cys variant (rs201131315) is reported in the literature in an individual affected with arrhythmogenic right ventricular cardiomyopathy (Forleo 2017). This variant was also found in an individual with hypertrophic cardiomyopathy that had other cardiac disease-related variants that may contribute to the phenotype (Lima da Silva 2018). The p.Tyr904Cys variant is reported in ClinVar (Variation ID: 179436) and is found in the general population with an overall allele frequency of 0.0146% (41/280,054 alleles) in the Genome Aggregation Database. Computational analyses predict that this variant is deleterious (REVEL: 0.956). Due to limited information, the clinical significance of this variant is uncertain at this time. References: Forleo C et al. Targeted next-generation sequencing detects novel gene-phenotype associations and expands the mutational spectrum in cardiomyopathies. PLoS One. 2017 Jul 27;12(7):e0181842. PMID: 28750076. Lima da Silva G et al. A Unique Case of Type-1 Facioscapulohumeral Muscular Dystrophy and Sarcomeric Hypertrophic Cardiomyopathy. Rev Esp Cardiol (Engl Ed). 2018 Sep;71(9):765-766. English, Spanish. PMID: 28697927. - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Dec 04, 2013 | The Tyr904Cys variant in RYR2 has not been previously reported in individuals wi th cardiomyopathy but has been identified in 0.1% (2/1500) chromosomes by the Cl inSeq Project (Ng 2013 and dbSNP rs201131315). Computational analyses (amino aci d biochemical properties, conservation, SIFT, AlignGVGD, PolyPhen-2) suggest tha t the Tyr904Cys variant may impact the protein, though this information is not p redictive enough to determine pathogenicity. Additional information is needed to fully assess its clinical significance. - |
Cardiomyopathy Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Color Diagnostics, LLC DBA Color Health | Oct 26, 2018 | - - |
Catecholaminergic polymorphic ventricular tachycardia 1 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 20, 2024 | - - |
RYR2-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 19, 2024 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Cardiovascular phenotype Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 30, 2020 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Pathogenic
D;D
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Pathogenic
D;D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D
MetaSVM
Pathogenic
D
MutationAssessor
Pathogenic
M;.
MutationTaster
Benign
D
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D;.
REVEL
Pathogenic
Sift
Uncertain
D;.
Polyphen
D;.
Vest4
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at